HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFF sales

This article was originally published in The Rose Sheet

Executive Summary

Third quarter North America fine fragrance and functional fragrance sales grew 17% and 9%, respectively, flavors and fragrances manufacturer reports Oct. 28. Consolidated sales grew 5% on a reported basis, or 2% at constant exchange rates, to $506.2 mil. Income results included $20 mil. in pre-tax restructuring and other charges related to the sale of certain European fruit business assets to Fruitarom and closure of Dijon, France manufacturing facility. Net income dropped 17% including the restructuring charges to $51 mil. Excluding the impact of the charges, net income increased 3%. IFF anticipates low to mid-single digit sales growth for the year in local currency, or high-single digit growth on a reported basis...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012569

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel